Biophysical analysis of the interaction of the serum protein human β2GPI with bacterial lipopolysaccharide

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 432-440

  Gries, Anna ^a   Prassl, Ruth ^a   Fukuoka, Satoshi ^b   Rössle, Manfred ^c   Kaconis, Yani ^d   Heinbockel, Lena ^d   Gutsmann, Thomas ^d   Brandenburg, Klaus ^d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b AIST Shikoku   (Japan)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Cytokine production; Immune modulation; LAL test; Lipopolysaccharide

Indexed keywords

BACTERIAL TOXIN; BACTERIUM LIPOPOLYSACCHARIDE; BETA2 GLYCOPROTEIN 1; HYDROCARBON; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLASMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IN VITRO STUDY; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; BILAYER MEMBRANE; BIOPHYSICS; CONTROLLED STUDY; CYTOKINE RELEASE; MEMBRANE FLUIDITY; PHASE TRANSITION; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; THERMODYNAMICS; TRANSITION TEMPERATURE;

BACTERIA (MICROORGANISMS);

EID: 84901231908     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.04.008     Document Type: Article

References (26)

1. Tapping R.I., Gegner J.A., Kravchenko V.V., Tobias P.S. Roles for LBP and soluble CD14 in cellular uptake of LPS. Prog. Clin. Biol. Res. 1998, 397:73-78.
2. Elass-Rochard E., Legrand D., Salmon V., Roseanu A., Trif M., Tobias P.S., Mazurier J., Spik G. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun. 1998, 66:486-491.
3. Schwarzenbacher R., Zeth K., Diederichs K., Gries A., Kostner G.M., Laggner P., Prassl R. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 1999, 18:6228-6239.
4. Bouma B., de Groot P.G., van Den Elsen J.M., Ravelli R.B., Schouten A., Simmelink M.J., Derksen R.H., Kroon J., Gros P. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 1999, 18:5166-5174.
5. Hammel M., Schwarzenbacher R., Gries A., Kostner G.M., Laggner P., Prassl R. Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes. Biochemistry 2001, 40:14173-14181.
6. Laplante P., Amireault P., Subang R., Dieude M., Levine J.S., Rauch J. Interaction of beta2-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages. J. Biol. Chem. 2011, 286:42494-42503.
7. Agar C., de Groot P.G., Morgelin M., Monk S.D., van Os G., Levels J.H., de Laat B., Urbanus R.T., Herwald H., van der P.T., Meijers J.C. Beta(2)-glycoprotein I: a novel component of innate immunity. Blood 2011, 117:6939-6947.
8. Alexander C., Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 2001, 7:167-202.
9. Galanos C., Luderitz O., Westphal O. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 1969, 9:245-249.
10. Gries A., Nimpf J., Wurm H., Kostner G.M., Kenner T. Characterization of isoelectric subspecies of asialo-beta 2-glycoprotein I. Biochem. J. 1989, 260:531-534.
11. Heinbockel L., Sanchez-Gomez S., Martinez D.T., Domming S., Brandenburg J., Kaconis Y., Hornef M., Dupont A., Marwitz S., Goldmann T., Ernst M., Gutsmann T., Schurholz T., Brandenburg K. Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors. Antimicrob. Agents Chemother. 2013, 57:1480-1487.
12. Roessle M.W., Klaering R., Ristau U., Robrahn B., Jahn D., Gehrmann T., Konarev P., Round A., Fiedler S., Hermes C., Svergun D. Upgrade of the small-angle X-ray scattering beamline X33 at the European Molecular Biology Laboratory, Hamburg. J. Appl. Crystallogr. 2007, 40:S190-S194.
13. Kaconis Y., Kowalski I., Howe J., Brauser A., Richter W., Razquin-Olazaran I., Inigo-Pestana M., Garidel P., Rössle M., Martinez de Tejada G., Gutsmann T., Brandenburg K. Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. Biophys. J. 2011, 100:2652-2661.
14. Brandenburg K., Seydel U. Infrared spectroscopy of glycolipids. Chem. Phys. Lipids 1998, 96:23-40.
15. Mantsch H.H., Chapman D. Infrared Spectroscopy of Biomolecules 1996, Wiley Press, New York.
16. Sanghera D.K., Wagenknecht D.R., McIntyre J.A., Kamboh M.I. Identification of structural mutations in the 5th domain of apolipoprotein H(beta-2-glycoprotein-I) which affect phospholipid-binding. Hum. Mol. Genet. 1997, 6:311-316.
17. Horbach D.A., Vanoort E., Tempelman M.J., Derksen R.H.W.M., Degroot P.G. The prevalence of a non-phospholipid-binding form of beta(2)-glycoprotein I in human plasma. Thromb. Haemost. 1998, 80:791-797.
18. Gamsjaeger R., Johs A., Gries A., Gruber H.J., Romanin C., Prassl R., Hinterdorfer P. Membrane binding of beta2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study. Biochem. J. 2005, 389:665-673.
19. Rappolt M., Rössle M., Kaconis Y., Howe J., Andra J., Gutsmann T., Brandenburg K. X-ray scattering of bacterial cell wall compounds and their neutralization. X-ray Scattering 2011, 133-148. NOVA Science Publisher, Hauppauge, NY. C. Bauwens (Ed.).
20. Paolorossi M., Montich G.G. Conformational changes of beta2-human glycoprotein I and lipid order in lipid-protein complexes. Biochim. Biophys. Acta 2011, 1808:2167-2177.
21. Borchman D., Harris E.N., Pierangeli S.S., Lamba O.P. Interactions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1). Clin. Exp. Immunol. 1995, 102:373-378.
22. Brandenburg K., Moriyon I., Arraiza M.D., Lewark-Yvetot G., Koch M.H.J., Seydel U. Biophysical investigations into the interaction of lipopolysaccharide with polymyxins. Thermochim. Acta 2002, 382:189-198.
23. Brandenburg K., Jurgens G., Andra J., Lindner B., Koch M.H., Blume A., Garidel P. Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins. Eur. J. Biochem. 2002, 269:5972-5981.
24. Brandenburg K., Jurgens G., Muller M., Fukuoka S., Koch M.H. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 2001, 382:1215-1225.
25. Andra J., Howe J., Garidel P., Rossle M., Richter W., Leiva-Leon J., Moriyon I., Bartels R., Gutsmann T., Brandenburg K. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis. Biochem. J. 2007, 406:297-307.
26. Ninivaggi M., Kelchtermans H., Lindhout T., de Laat B. Conformation of beta2glycoprotein I and its effect on coagulation. Thromb. Res. 2012, 130(Suppl. 1):S33-S36.